Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells
IntroductionAdoptive cell therapy using TCR-engineered T-cells is one of the most effective strategies against tumor cells. The TCR T-cell approach has been well tested against a variety of blood neoplasms but is yet to be deeply tested against solid tumors. Among solid tumors, cancer-testis antigen...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-10-01
|
| シリーズ: | Frontiers in Immunology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1470130/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
